Your search history is turned on.
Date: May 3, 2024 18:08:19 EST Jurisdictions: Alberta, British Columbia, Ontario
BetterLife Announces Intent to Complete Private Placement of Units VANCOUVER, British Columbia, May 03, 2024 -- BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to complete a No...
Date: May 1, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BetterLife Advances BETR-001 IND-enabling Studies VANCOUVER, British Columbia, May 01, 2024 -- BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, announces that it has advanced in its IND-enabling studies for BETR-001, a...
Date: April 12, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Via SEDAR+ RE: BetterLife Pharma Inc. (the "Issuer") Notice of Meeting and Record Dates 1 Meeting Type Annual General Meeting 2 Record Date for Notice of Meeting May 9, 2024 3 Record Date for Voting (If Applicable) May 9, 2024 4 Beneficial Ownership Determination Date May 9, 2024 5 Meeting Date June 25, 2024 6 Meeting Location Virtually 7 Voting Sec...
Date: April 11, 2024 Jurisdictions: Alberta, British Columbia, Ontario
April 2, 2004 (2004) 27 OSCB 3524 FORM 51-102F3 MATERIAL CHANGE REPORT PART 1 GENERAL INSTRUCTIONS AND INTERPRETATION (a) Confidentiality If this Report is filed on a confidential basis, state in block capitals CONFIDENTIAL at the beginning of th FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company ...
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference VANCOUVER, British Columbia, April 11, 2024 -- BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce that Dr. Ahmad Doroudian, Chie...
Date: April 4, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - 2024-04-04 BETR MCR - Conv debt FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company BetterLife Pharma Inc. (the Company) 1275 West 6th Avenue Suite 300 Vancouver, British Columbia V6H 1A6 Item 2 Date of Material Change March and April 2024 Item 3 News Releases News release dated April 3, 2024 ...
Date: April 3, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001 VANCOUVER, British Columbia, April 03, 2024 -- BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge...
Date: March 14, 2024 Jurisdictions: British Columbia
Create report of exempt distribution (Form 45-106F1) Form 45-106F1 Report of Exempt Distribution ITEM 1 - REPORT TYPE New report Amended report If amended, provide filing date of report that is being amended. (YYYY-MM-DD) ITEM 2 - PARTY CERTIFYING THE REPORT Indicate the party certifying the report (select only one). For guidance regarding whether an ...
Date: March 6, 2024 Jurisdictions: British Columbia
Date: March 5, 2024 Jurisdictions: Alberta, British Columbia, Ontario
April 2, 2004 (2004) 27 OSCB 3524 FORM 51-102F3 MATERIAL CHANGE REPORT PART 1 GENERAL INSTRUCTIONS AND INTERPRETATION (a) Confidentiality If this Report is filed on a confidential basis, state in block capitals CONFIDENTIAL at the beginning of th FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company BetterLife Pharma Inc. ...